InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Vanda Pharmaceuticals Inc.

VNDA Clue Score24
United States Fiscal year ends December CIK 0001347178 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Gunther Birznieks
2 Mar 2026
SVP, Business Development
Sell
42,431
$8.27
$350.73K
Mihael Hristos Polymeropoulos
2 Mar 2026
President and CEO
Sell
156,235
$8.17
$1.28M
Joakim Wijkstrom
2 Mar 2026
SVP, Chief Marketing Officer
Sell
30,800
$8.27
$254.59K
Kevin Patrick Moran
2 Mar 2026
SVP, CFO & Treasurer
Sell
42,442
$8.27
$350.82K
Timothy Williams
2 Mar 2026
SVP & General Counsel
Sell
42,434
$8.27
$350.76K
Tage Honore
23 Feb 2026
Director
Sell
30,000
$8.03
$240.90K
Show all 9 transactions →

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 1,437,537
History held since 3 Nov 2006